Literature DB >> 15348228

Immobilization of the thrombin inhibitor r-hirudin conserving its biological activity.

J Lahann1, W Plüster, D Klee, H G Gattner, H Höcker.   

Abstract

Surface immobilization of the thrombin inhibitor r-hirudin was carried out on two different polymers. Linkage to poly(urethane-graft-acrylic acid) (PAC/PU) was done via carboxylic acid groups, using a water soluble carbodimide, while the immobilization on a modified poly[(ethene-co-vinyl acetate)-graft-vinyl chloride] (PVC/EVA) was achieved via the alcohol groups of the polymer using HDI as spacer. Direct immobilization of r-hirudin leaded to a remarkable loss of thrombin activity. As proved by means of protein chemical analysis, loss of activity was due to a selective coupling via the N-terminal amino group of r-hirudin, which is essential for its thrombin activity. Based on these results we developed an immobilization method via an epsilon-amino group of r-hirudin preserving full biological activity of the r-hirudin coated surface. Copyright 2001 Kluwer Academic Publishers

Entities:  

Year:  2001        PMID: 15348228     DOI: 10.1023/a:1013929103147

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  9 in total

1.  The methylsulfonylethyloxycarbonyl group, a new and versatile amino protective function.

Authors:  G I Tesser; I C Balvert-Geers
Journal:  Int J Pept Protein Res       Date:  1975

2.  Thrombin plays a pivotal role in vascular re-occlusion after PTCA and coronary thrombolysis.

Authors:  G Agnelli
Journal:  Cardiovasc Res       Date:  1996-02       Impact factor: 10.787

Review 3.  Molecular Interactions of Thrombin.

Authors:  A Tulinsky
Journal:  Semin Thromb Hemost       Date:  1996       Impact factor: 4.180

4.  Bioactive immobilization of r-hirudin on CVD-coated metallic implant devices.

Authors:  J Lahann; D Klee; W Pluester; H Hoecker
Journal:  Biomaterials       Date:  2001-04       Impact factor: 12.479

Review 5.  Design of nonthrombogenic polymer surfaces for blood-contacting medical devices.

Authors:  S W Kim; H Jacobs
Journal:  Blood Purif       Date:  1996       Impact factor: 2.614

6.  The functional domain of hirudin, a thrombin-specific inhibitor.

Authors:  J Y Chang
Journal:  FEBS Lett       Date:  1983-12-12       Impact factor: 4.124

Review 7.  Heparin-induced thrombocytopenia. Pathogenesis, frequency, avoidance and management.

Authors:  T E Warkentin
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

Review 8.  Thrombin receptor antagonists.

Authors:  S M Seiler
Journal:  Semin Thromb Hemost       Date:  1996       Impact factor: 4.180

9.  The structure of a complex of recombinant hirudin and human alpha-thrombin.

Authors:  T J Rydel; K G Ravichandran; A Tulinsky; W Bode; R Huber; C Roitsch; J W Fenton
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

  9 in total
  2 in total

1.  Tailoring biomaterial surface properties to modulate host-implant interactions: implication in cardiovascular and bone therapy.

Authors:  Settimio Pacelli; Vijayan Manoharan; Anna Desalvo; Nikita Lomis; Kartikeya Singh Jodha; Satya Prakash; Arghya Paul
Journal:  J Mater Chem B       Date:  2015-10-16       Impact factor: 6.331

2.  In vitro functional testing of endothelial progenitor cells that overexpress thrombomodulin.

Authors:  John D Stroncek; Yujing Xue; Nabila Haque; Jeffrey H Lawson; William M Reichert
Journal:  Tissue Eng Part A       Date:  2011-05-25       Impact factor: 3.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.